Novant Health Medical Group, LLC
Novant Health Medical Group, LLC was paid $8.57M by Medicaid between Jan 2018 and Dec 2024, across 57 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
MONROE, NC 28110
Next to other Pediatrics Physician providers in North Carolina
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,704 | $912K | |
| 2019 | 30,622 | $1.23M | |
| 2020 | 28,132 | $1.20M | |
| 2021 | 70,702 | $1.93M | |
| 2022 | 83,020 | $2.06M | |
| 2023 | 60,020 | $1.13M | |
| 2024incomplete | 42,956 | $114K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 32,322 | 27,829 | $3.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 20,357 | 17,230 | $1.32M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.2% | 8,590 | 6,987 | $787K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.5% | 12,769 | 11,014 | $639K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.2% | 6,266 | 5,430 | $618K |
| 99199 | Unlisted special service, procedure or report | 5.6% | 135,146 | 132,550 | $481K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.5% | 6,262 | 5,134 | $300K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.4% | 2,111 | 1,822 | $205K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.9% | 5,753 | 4,918 | $165K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.6% | 7,653 | 6,311 | $135K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 14,337 | 12,423 | $126K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 8,267 | 3,753 | $111K |
45 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 11,362 | $102K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 858 | $90K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,176 | $78K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,192 | $68K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,055 | $67K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 1,357 | $48K |
| 96127 | <1% | 10,908 | $47K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,378 | $31K |
| 87807 | <1% | 2,086 | $28K | |
| D1206 | Topical application of fluoride varnish | <1% | 1,357 | $21K |
| 81003 | <1% | 7,159 | $11K | |
| 90461 | <1% | 7,904 | $10K | |
| 90474 | <1% | 455 | $9K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 160 | $6K |
| 99381 | <1% | 64 | $6K | |
| 90651 | <1% | 135 | $5K | |
| 90686 | <1% | 3,562 | $5K | |
| 96161 | <1% | 699 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 734 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 16 | $2K |
| 92551 | <1% | 4,593 | $1K | |
| 99051 | <1% | 54 | $1K | |
| 90734 | <1% | 62 | $790.16 | |
| 99173 | <1% | 4,367 | $468.55 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 38 | $386.84 |
| 92567 | <1% | 30 | $381.92 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 18 | $319.03 |
| 99177 | <1% | 1,813 | $278.73 | |
| 90674 | <1% | 973 | $258.94 | |
| 90670 | <1% | 5,282 | $224.49 | |
| 88720 | <1% | 16 | $101.02 | |
| 90633 | <1% | 1,026 | $68.73 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $51.80 |
| 90680 | 0% | 2,586 | $0.00 | |
| 90698 | 0% | 2,394 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 38 | $0.00 |
| 90744 | 0% | 690 | $0.00 | |
| 90723 | 0% | 563 | $0.00 | |
| 90732 | 0% | 12 | $0.00 | |
| 90716 | 0% | 15 | $0.00 | |
| 90648 | 0% | 1,052 | $0.00 | |
| 92552 | 0% | 12 | $0.00 | |
| 90707 | 0% | 16 | $0.00 | |
| 90700 | 0% | 28 | $0.00 | |
| 90687 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.